Allstate (ALL) insider exercises awards and sells 33,986 shares in 10b5-1 trades

Rhea-AI Filing Summary

Allstate Corporation insider Jesse E. Merten reported a combination of equity awards exercises and stock sales. On February 24–25, 2026, he acquired Allstate common shares by exercising employee stock options and converting restricted stock units, then sold 33,986 common shares in open-market transactions executed under a Rule 10b5-1 trading plan adopted on November 7, 2025.

The reported sale prices were weighted averages between $206.96 and $210.47 per share across several price brackets. After these transactions, he directly owned 32,301 Allstate common shares and indirectly held 7,823 shares through a 401(k) plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Merten Jesse E

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			PresPersonalProperty-Liability

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		M		1,201	A	$0(1)	32,834	D
Common Stock	02/24/2026		F		533	D	$209.82	32,301	D
Common Stock	02/25/2026		M		12,879	A	$122.64(2)	45,180	D
Common Stock	02/25/2026		M		1,734	A	$133(2)	46,914	D
Common Stock	02/25/2026		M		19,373	A	$137.1(2)	66,287	D
Common Stock	02/25/2026		S		8,811	D	$207.5314(2)(3)	57,476	D
Common Stock	02/25/2026		S		15,893	D	$208.5753(2)(4)	41,583	D
Common Stock	02/25/2026		S		7,982	D	$209.4048(2)(5)	33,601	D
Common Stock	02/25/2026		S		1,300	D	$210.4385(2)(6)	32,301	D
Common Stock								7,823	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/24/2026		M			1,201	(1)	02/24/2028	Common Stock	1,201	$0	2,402	D
Employee Stock Option (Right to Buy)	$122.64	02/25/2026		M			12,879(2)	02/17/2025	02/17/2032	Common Stock	12,879	$0	0	D
Employee Stock Option (Right to Buy)	$133	02/25/2026		M			1,734(2)	10/05/2025	10/05/2032	Common Stock	1,734	$0	868	D
Employee Stock Option (Right to Buy)	$137.1	02/25/2026		M			19,373(2)	02/16/2026	02/16/2033	Common Stock	19,373	$0	9,687	D

Explanation of Responses:

1. Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028.

2. The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025.

3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $206.96 to $207.86. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.96 to $208.95. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

5. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.97 to $209.96. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

6. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.06 to $210.47. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

	/s/ Meghan E. Jauhar, attorney-in-fact for Jesse E. Merten	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Allstate (ALL) insider Jesse E. Merten report in this Form 4?

Jesse E. Merten reported exercising employee stock options and restricted stock units, then selling 33,986 Allstate common shares in open-market trades. The activity reflects routine equity compensation transactions rather than a new corporate event or change in the company’s underlying business performance.

How many Allstate (ALL) shares did Jesse E. Merten sell and at what prices?

He sold 33,986 Allstate common shares in open-market transactions on February 25, 2026. The reported weighted average sale prices ranged from $206.96 to $210.47 per share, with specific brackets disclosed through multiple weighted-average price footnotes in the filing.

Were Jesse E. Merten’s Allstate (ALL) stock sales under a 10b5-1 trading plan?

Yes. The filing notes the option exercise and sale transactions were executed under a Rule 10b5-1 trading plan adopted on November 7, 2025. Such plans pre-schedule trades, helping separate personal trading decisions from day-to-day corporate information flows.

How many Allstate (ALL) shares does Jesse E. Merten hold after these transactions?

Following the reported transactions, he directly owned 32,301 Allstate common shares. The filing also shows an additional 7,823 shares held indirectly through a 401(k) plan, indicating continued exposure to the company’s equity after the option exercises and sales.

What role do restricted stock units and options play in this Allstate (ALL) Form 4?

The Form 4 shows the conversion of previously awarded restricted stock units and the exercise of employee stock options into common shares. These equity awards were granted under The Allstate Corporation 2019 Equity Incentive Plan and then partially monetized through open-market sales.